<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="deo270092" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">DEN Open</journal-id><journal-id journal-id-type="iso-abbrev">DEN Open</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2692-4609</journal-id><journal-id journal-id-type="publisher-id">DEO2</journal-id><journal-title-group><journal-title>DEN Open</journal-title></journal-title-group><issn pub-type="epub">2692-4609</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40046941</article-id><article-id pub-id-type="pmc">PMC11880624</article-id>
<article-id pub-id-type="doi">10.1002/deo2.70092</article-id><article-id pub-id-type="publisher-id">DEO270092</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Difficult biliary cannulation during endoscopic retrograde cholangiopancreatography for distal malignant biliary obstruction caused by pancreatic cancer: An observational study</article-title><alt-title alt-title-type="left-running-head">NODA <sc>et&#x000a0;al</sc>.</alt-title></title-group><contrib-group><contrib id="deo270092-cr-0001" contrib-type="author" corresp="yes"><name><surname>Noda</surname><given-names>Jun</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0006-1254-9246</contrib-id><xref rid="deo270092-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>nodaji0317@med.showa-u.ac.jp</email></address></contrib><contrib id="deo270092-cr-0002" contrib-type="author"><name><surname>Takano</surname><given-names>Yuichi</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6803-9460</contrib-id><xref rid="deo270092-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270092-cr-0003" contrib-type="author"><name><surname>Tamai</surname><given-names>Naoki</given-names></name><xref rid="deo270092-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270092-cr-0004" contrib-type="author"><name><surname>Yamawaki</surname><given-names>Masataka</given-names></name><xref rid="deo270092-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270092-cr-0005" contrib-type="author"><name><surname>Azami</surname><given-names>Tetsushi</given-names></name><xref rid="deo270092-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270092-cr-0006" contrib-type="author"><name><surname>Niiya</surname><given-names>Fumitaka</given-names></name><xref rid="deo270092-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270092-cr-0007" contrib-type="author"><name><surname>Maruoka</surname><given-names>Naotaka</given-names></name><xref rid="deo270092-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270092-cr-0008" contrib-type="author"><name><surname>Nagahama</surname><given-names>Masatsugu</given-names></name><xref rid="deo270092-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="deo270092-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Internal Medicine, Division of Gastroenterology</named-content>
<institution>Showa University Fujigaoka Hospital</institution>
<named-content content-type="country-part">Kanagawa</named-content>
<country country="JP">Japan</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>: Jun Noda, Department of Internal Medicine, Division of Gastroenterology, Showa University Fujigaoka Hospital, 1&#x02010;30, Fujigaoka, Aoba&#x02010;ku, Yokohama, Kanagawa, 227&#x02010;8501, Japan.<break/>Email: <email>nodaji0317@med.showa-u.ac.jp</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>04</day><month>3</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2025</year></pub-date><volume>5</volume><issue seq="23">1</issue><issue-id pub-id-type="doi">10.1002/deo2.v5.1</issue-id><elocation-id>e70092</elocation-id><history>
<date date-type="rev-recd"><day>17</day><month>2</month><year>2025</year></date>
<date date-type="received"><day>15</day><month>12</month><year>2024</year></date>
<date date-type="accepted"><day>23</day><month>2</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">DEN Open</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:DEO2-5-e70092.pdf"/><abstract><title>Abstract</title><sec id="deo270092-sec-0010"><title>Objectives</title><p>Distal malignant biliary obstruction (DMBO) caused by pancreatic cancer often complicates endoscopic retrograde cholangiopancreatography (ERCP), particularly biliary cannulation. While various factors influencing difficult biliary cannulation (DBC) have been studied, data specific to pancreatic cancer&#x02010;related distant malignant biliary obstruction#x000A0;remains limited. This study identifies factors affecting ERCP success in this patient population to improve clinical outcomes.</p></sec><sec id="deo270092-sec-0020"><title>Methods</title><p>We retrospectively analyzed 119 ERCP procedures for distant malignant biliary obstruction owing to pancreatic cancer with na&#x000ef;ve papilla at Showa University Fujigaoka Hospital (January 2020&#x02013;September 2024). Patient characteristics, duodenal invasion, ampullary bile duct status, papillary morphology, trainee involvement, and adverse events were evaluated. Multivariate analysis identified predictive factors of DBC.</p></sec><sec id="deo270092-sec-0030"><title>Results</title><p>After excluding 17 ERCP failures, 102 patients were analyzed and categorized into non&#x02010;DBC (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;40) and DBC (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;62) groups. The DBC incidence rate was 60.8%. The absence of the ampullary bile duct (odds ratio [OR]: 2.58, 95% confidence interval [CI]: 1.02&#x02013;6.51; <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.04) and the macroscopic appearance of type III papillary morphology (enlarged/protruding; OR: 3.32; 95% CI: 1.07&#x02013;10.30; <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.04) were significantly associated with DBC. Adverse events were slightly more frequent in the DBC group; however, this difference was not statistically significant. Alternative cannulation was performed more often in patients without the ampullary bile duct; however, no difference in adverse events was observed.</p></sec><sec id="deo270092-sec-0040"><title>Conclusions</title><p>The absence of the ampullary bile duct and type III papillary morphology are anatomical risk factors for DBC during ERCP for patients with pancreatic cancer. Early consideration of alternative cannulation techniques or biliary drainage methods may be necessary for such patients.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="deo270092-kwd-0001">bile ducts</kwd><kwd id="deo270092-kwd-0002">cholangiopancreatography</kwd><kwd id="deo270092-kwd-0003">drainage</kwd><kwd id="deo270092-kwd-0004">pancreatic carcinoma</kwd><kwd id="deo270092-kwd-0005">retrospective studies</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>None.</funding-source></award-group></funding-group><counts><fig-count count="3"/><table-count count="3"/><page-count count="9"/><word-count count="4697"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:07.04.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="deo270092-sec-0050"><title>INTRODUCTION</title><p>Endoscopic retrograde cholangiopancreatography (ERCP) is a complex therapeutic endoscopy procedure, with deep biliary cannulation being a critical initial step.<xref rid="deo270092-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> However, difficult biliary cannulation (DBC) occurs in some patients, posing a significant challenge.</p><p>The European Society of Gastrointestinal Endoscopy defines DBC based on the &#x0201c;5&#x02010;5&#x02010;1 criteria,&#x0201d; which include five or more cannulation attempts over 5&#x000a0;min to achieve cannulation after contacting the papilla and multiple inadvertent pancreatic duct cannulations or opacifications.<xref rid="deo270092-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> The reported incidence of DBC ranges from 5% to 49%, with an average of approximately 20%.<xref rid="deo270092-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="deo270092-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>
</p><p>Several factors have been identified as potential predictors of DBC, including distal malignant biliary obstruction (DMBO) caused by pancreatic cancer, the experience of the endoscopist, and papillary anatomy.<xref rid="deo270092-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>&#x02013;&#x02010;</sup>
<xref rid="deo270092-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> DMBO owing to pancreatic cancer is a common indication for ERCP,<xref rid="deo270092-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> yet studies specifically addressing factors associated with DBC in this patient group remain limited. Compared to bile duct and ampullary cancers, pancreatic cancer is linked to a higher risk of DBC<xref rid="deo270092-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> and longer cannulation times.<xref rid="deo270092-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>
</p><p>Pancreatic tumors can distort the duodenal and papillary anatomy through compression or direct invasion, further complicating cannulation.<xref rid="deo270092-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> Direct duodenum invasion is a known risk factor for ERCP failure.<xref rid="deo270092-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> However, even in cases where the duodenum and papilla appear normal, the absence of a visible bile duct opening at the papilla may contribute to DBC, possibly due to the lack of an ampullary bile duct.</p><p>Identifying high&#x02010;risk patients enables endoscopists to select the most appropriate cannulation techniques, improving procedural success. Therefore, this study identified the predictors of DBC in patients with DMBO caused by pancreatic cancer, incorporating the absence of a papillary bile duct alongside previously reported risk factors, such as papillary morphology and trainee involvement.</p></sec><sec id="deo270092-sec-0060"><title>METHODS</title><sec id="deo270092-sec-0070"><title>Patients</title><p>We retrospectively analyzed ERCP data from Showa University Fujigaoka Hospital between January 1, 2020, and September 30, 2024, to identify factors associated with DBC in patients with DMBO owing to pancreatic cancer. Inclusion criteria were patients with DMBO caused by pancreatic cancer and a na&#x000ef;ve papilla for ERCP. Exclusion criteria included surgically altered anatomy, ERCP failure due to duodenal obstruction, and insufficient data.</p></sec><sec id="deo270092-sec-0080"><title>ERCP procedure</title><p>The patient was sedated using 35&#x000a0;mg pethidine hydrochloride and 2&#x02013;5&#x000a0;mg midazolam, followed by insertion of a standard duodenoscope (JF260&#x000a0;V, TJF&#x02010;Q260&#x000a0;V, or TJF&#x02010;290&#x000a0;V; Olympus Medical Systems). A tapered catheter (PR&#x02010;V614&#x000a0;M; Olympus) with an angled&#x02010;tip 0.025&#x02010;inch guide wire (Visiglide2; Olympus) was used. If conventional bile duct cannulation (contrast&#x02010; and wire&#x02010;guided) failed, and the guidewire entered the pancreatic duct, the double&#x02010;guidewire technique (DGW) or transpancreatic biliary sphincterotomy (TPBS) was attempted using a sphincterotome (CleverCut3&#x000a0;V; Olympus). If the pancreatic duct could not be accessed, a direct precutting technique was applied at the endoscopist's discretion of the endoscopist. Prophylactic pancreatic stent placement was optional, and rectal diclofenac, along with large&#x02010;volume fluid administration, was used to prevent post&#x02010;ERCP pancreatitis (PEP). If intubation was difficult, we promptly attempted alternative cannulation methods, with trainees performing TPBS or direct precutting. If successful, trainees proceeded under expert supervision; otherwise, an expert took over after 15&#x02013;20&#x000a0;min. Endoscopic sphincterotomy was performed unless contraindicated by bleeding risk or anticoagulant use, in which case endoscopic papillary balloon dilation was performed with an 8&#x02010;mm balloon. Plastic stents (7&#x02010;Fr or 8.5&#x02010;Fr, straight or pigtail) or fully covered metal stents (8 or 10&#x000a0;mm in diameter and 6 or 8&#x000a0;cm in length) were used as needed.</p></sec><sec id="deo270092-sec-0090"><title>Definitions and outcomes</title><p>DBC was defined by the 5&#x02010;5&#x02010;1 criteria of the European Society of Gastrointestingal Endoscopy: cannulation time &#x02265;5&#x000a0;min; &#x02265;5 catheter insertion attempts; or &#x02265;1 pancreatic duct cannulation.<xref rid="deo270092-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> Patients who were handed over from the trainee to the expert and then successfully cannulated shortly thereafter were classified into the non&#x02010;DBC group. Successful biliary cannulation was defined as deep cannulation of the bile duct, with cannulation time measured from scope insertion to deep cannulation using timestamps from endoscopic and fluoroscopic images. Cholangitis was defined according to the 2018 Tokyo Guidelines proposed by the Japan Society of Hepato&#x02010;Biliary&#x02010;Pancreatic Surgery. <xref rid="deo270092-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> Clinical stage was determined using the 8th edition of the TNM classification by the Japan Pancreas Society.<xref rid="deo270092-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>
</p><p>The absence of the ampullary bile duct was defined as a continuous stricture &#x02265;5&#x000a0;mm from the ampullary region, observed on preoperative computed tomography (Figure&#x000a0;<xref rid="deo270092-fig-0001" ref-type="fig">1</xref>). The duodenal invasion was defined as a tumor invasion observed during endoscopy.</p><fig position="float" fig-type="FIGURE" id="deo270092-fig-0001"><label>FIGURE 1</label><caption><p>Schematic diagram and computed tomography image showing the absence of the ampullary bile duct (red arrow).</p></caption><graphic xlink:href="DEO2-5-e70092-g003" position="anchor" id="jats-graphic-1"/></fig><p>Papillary morphology was classified according to Haraldsson's category: type I, normal; type II, small; type III, enlarged/protruding; and type IV, ridged (Figure&#x000a0;<xref rid="deo270092-fig-0002" ref-type="fig">2</xref>).<xref rid="deo270092-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> Type III papilla classification followed Watanabe et&#x000a0;al., measuring the length of the oral protrusion using the marker at the ERCP catheter tip. Periampullary diverticula were documented and classified using Boix's categories (types I, II, and III).<xref rid="deo270092-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>
</p><fig position="float" fig-type="FIGURE" id="deo270092-fig-0002"><label>FIGURE 2</label><caption><p>Macroscopic ampullary appearance types I&#x02013;IV according to Haraldsson's classification.</p></caption><graphic xlink:href="DEO2-5-e70092-g002" position="anchor" id="jats-graphic-3"/></fig><p>Experts were defined as physicians with &#x02265;400 ERCP procedures; trainees had performed fewer than 400.<xref rid="deo270092-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> At our institution, trainees are not beginners in initial ERCP for DMBO, having completed&#x000a0;&#x0003e;50 procedures. Three experts and five trainees participated in this study.</p><p>Adverse events (AEs) were defined and graded according to the American Society for Gastrointestinal Endoscopy severity system.<xref rid="deo270092-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> Pancreatitis was diagnosed with abdominal pain and serum amylase &#x02265;3 times the upper normal limit. Bleeding was confirmed by visible evidence and a hemoglobin decrease of&#x000a0;&#x0003c;3&#x000a0;g/dL. Perforation was confirmed by the presence of air or luminal contents outside the gastrointestinal tract. Outcomes were defined as differences in predictive factors for DBC, AEs, and alternative cannulation between the non&#x02010;DBC and DBC groups.</p></sec><sec id="deo270092-sec-0100"><title>Statistical analysis</title><p>Continuous variables were presented as medians with interquartile ranges and analyzed using the Mann&#x02013;Whitney U test. Categorical variables were expressed as proportions and compared using Fisher's exact test. A multivariate logistic regression analysis assessed factors associated with DBC, including duodenal invasion, absence of the ampullary bile duct, trainee involvement, and papillary morphology. <italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.05 was considered statistically significant. All analyses were conducted using R version 3.4.1 (The R Foundation for Statistical Computing).</p></sec></sec><sec id="deo270092-sec-0110"><title>RESULTS</title><sec id="deo270092-sec-0120"><title>Patient characteristics</title><p>Between January 1, 2020, and September 30, 2024, 119 patients with DMBO due to pancreatic cancer and na&#x000ef;ve papilla undergoing ERCP were screened. Seventeen patients were excluded due to ERCP failure caused by duodenal obstruction (13 switched to endoscopic ultrasound&#x02010;guided biliary drainage [EUS&#x02010;BD], one to percutaneous transhepatic gallbladder drainage, and three discontinued due to worsening condition). Therefore, 102 patients were included in the analysis: 40 and 62 in the non&#x02010;DBC and DBC groups, respectively (Figure&#x000a0;<xref rid="deo270092-fig-0003" ref-type="fig">3</xref>).</p><fig position="float" fig-type="FIGURE" id="deo270092-fig-0003"><label>FIGURE 3</label><caption><p>Patient flow chart. DBC, difficult biliary cannulation; DMBO, distal malignant biliary obstruction; ERCP, endoscopic retrograde cholangiopancreatography.</p></caption><graphic xlink:href="DEO2-5-e70092-g001" position="anchor" id="jats-graphic-5"/></fig><p>Table&#x000a0;<xref rid="deo270092-tbl-0001" ref-type="table">1</xref> summarizes the patient characteristics. The median age in the non&#x02010;DBC group was 73.5 years, and in the DBC group, it was 76.5 years. The proportion of females was similar in both groups: 57.5% in the non&#x02010;DBC group and 53.2% in the DBC group. The median pre&#x02010;ERCP total bilirubin levels were 5.15 and 6.5&#x000a0;mg/dL in the non&#x02010;DBC and DBC groups, respectively; this difference was not statistically significant. The median bile duct diameters were 15&#x000a0;mm and 16&#x000a0;mm in the non&#x02010;DBC and DBC groups, respectively. The median lengths of the bile duct stricture measured using fluoroscopy were 25.5 and 23.5&#x000a0;mm in the non&#x02010;DBC and DBC groups, respectively.</p><table-wrap position="float" id="deo270092-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Baseline parameters, endoscopic procedure characteristics, and clinical outcomes of the patients.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">
<p>Non&#x02010;DBC group</p>
<p>
<italic toggle="yes">n</italic>&#x000a0;= 40</p>
</th><th align="left" rowspan="1" colspan="1">
<p>DBC group</p>
<p>
<italic toggle="yes">n</italic>&#x000a0;= 62</p>
</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, median [IQR], (years)</td><td align="left" rowspan="1" colspan="1">73.5 (43&#x02013;96)</td><td align="left" rowspan="1" colspan="1">76.5 (34&#x02013;93)</td><td align="left" rowspan="1" colspan="1">0.147</td></tr><tr><td align="left" rowspan="1" colspan="1">Female sex, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">23 (57.5)</td><td align="left" rowspan="1" colspan="1">33 (53.2)</td><td align="left" rowspan="1" colspan="1">0.689</td></tr><tr><td align="left" rowspan="1" colspan="1">Total bilirubin before the ERCP procedure, median [IQR], (mg/dL)</td><td align="left" rowspan="1" colspan="1">5.15 (0.3&#x02013;27)</td><td align="left" rowspan="1" colspan="1">6.5 (0.6&#x02013;26)</td><td align="left" rowspan="1" colspan="1">0.671</td></tr><tr><td align="left" rowspan="1" colspan="1">Presence of cholangitis, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">4 (10.0)</td><td align="left" rowspan="1" colspan="1">5 (8.1)</td><td align="left" rowspan="1" colspan="1">0.735</td></tr><tr><td align="left" rowspan="1" colspan="1">Bile duct diameter, median [IQR], (mm)</td><td align="left" rowspan="1" colspan="1">15 (9&#x02013;32)</td><td align="left" rowspan="1" colspan="1">16 (7&#x02013;29)</td><td align="left" rowspan="1" colspan="1">0.404</td></tr><tr><td align="left" rowspan="1" colspan="1">Bile duct stricture length on CT, median [IQR], (mm)</td><td align="left" rowspan="1" colspan="1">25.5 (9&#x02013;45)</td><td align="left" rowspan="1" colspan="1">23.5 (8&#x02013;45)</td><td align="left" rowspan="1" colspan="1">0.755</td></tr><tr><td align="left" rowspan="1" colspan="1">Clinical stage, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.423</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Stage I</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">2 (3.2)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Stage II</td><td align="left" rowspan="1" colspan="1">15 (37.5)</td><td align="left" rowspan="1" colspan="1">15 (24.2)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Stage III</td><td align="left" rowspan="1" colspan="1">11 (27.5)</td><td align="left" rowspan="1" colspan="1">22 (35.5)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Stage IV</td><td align="left" rowspan="1" colspan="1">14 (35.0)</td><td align="left" rowspan="1" colspan="1">23 (37.1)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Treatment policy, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.506</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Surgery</td><td align="left" rowspan="1" colspan="1">8 (20.0)</td><td align="left" rowspan="1" colspan="1">10 (16.1)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Chemotherapy</td><td align="left" rowspan="1" colspan="1">10 (25.0)</td><td align="left" rowspan="1" colspan="1">22 (35.5)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Best supportive care</td><td align="left" rowspan="1" colspan="1">22 (55.0)</td><td align="left" rowspan="1" colspan="1">30 (48.4)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Cannulation time, median [IQR], (min)</td><td align="left" rowspan="1" colspan="1">4.5 (1&#x02013;5)</td><td align="left" rowspan="1" colspan="1">21.5 (4&#x02013;54)</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001*</td></tr><tr><td align="left" rowspan="1" colspan="1">Cannulation method, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0003c;0.001*</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Normal</td><td align="left" rowspan="1" colspan="1">40 (100)</td><td align="left" rowspan="1" colspan="1">9 (14.5)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Double&#x02010;guidewire</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">33 (53.2)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">TPBS</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">11 (17.7)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Direct precutting</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">9 (14.5)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Papilla treatment, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.886</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">None</td><td align="left" rowspan="1" colspan="1">2 (5.70)</td><td align="left" rowspan="1" colspan="1">2 (3.2)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">EST</td><td align="left" rowspan="1" colspan="1">36 (90.0)</td><td align="left" rowspan="1" colspan="1">56 (90.3)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">EPBD</td><td align="left" rowspan="1" colspan="1">2 (5.0)</td><td align="left" rowspan="1" colspan="1">4 (6.0)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Biliary stenting, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Plastic stent</td><td align="left" rowspan="1" colspan="1">31 (77.5)</td><td align="left" rowspan="1" colspan="1">49 (79.0)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Metallic stent</td><td align="left" rowspan="1" colspan="1">9 (22.5)</td><td align="left" rowspan="1" colspan="1">13 (21.0)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Adverse events, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.126</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Pancreatitis (mild)</td><td align="left" rowspan="1" colspan="1">1 (2.5)</td><td align="left" rowspan="1" colspan="1">7 (11.3)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Bleeding</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">3 (4.8)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Perforation</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="deo270092-tbl1-note-0001"><p>Abbreviations: CT, computed tomography; DBC, difficult biliary cannulation; EPBD, endoscopic papillary balloon dilatation; ERCP, endoscopic retrograde cholangiopancreatography; EST, endoscopic sphincterotomy; IQR interquartile range; TPBS, transpancreatic biliary sphincterotomy.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>The biliary cannulation time significantly differed between groups. The median biliary cannulation time in the non&#x02010;DBC and DBCs groups was 4.5 and 21.5&#x000a0;min, respectively. All patients in the non&#x02010;DBC group underwent conventional cannulation, whereas the DBC group included patients with a cannulation time of &#x02265;5&#x000a0;min using the conventional technique (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;9, 14.6%), those who underwent only the double&#x02010;guidewire technique (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;33, 53.2%), those who had the double&#x02010;guidewire technique followed by TPBS (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;11, 17.7%), and those requiring direct precutting after failed double&#x02010;guidewire attempts (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;9, 14.5%).</p><p>No significant differences in AE rates were observed between the groups, although the DBC group had a higher AE rate. Mild pancreatitis occurred in one (2.5%) patient in the non&#x02010;DBC group and seven (11.3%) in the DBC group, but this difference was not statistically significant. Bleeding was observed in three (4.8%) patients in the DBC group, but this finding was also not statistically significant.</p></sec><sec id="deo270092-sec-0130"><title>Factors predictive of DBC</title><p>Table&#x000a0;<xref rid="deo270092-tbl-0002" ref-type="table">2</xref> presents the prevalence of factors predictive of DBC, along with the results of the univariate and multivariate analyses. Regarding papillary morphology, 12.5% and 30.6% of patients in the non&#x02010;DBC and DBC groups, respectively, were classified as type III. Periampullary diverticula were observed in 15.0% and 4.8% of type I cases in the non&#x02010;DBC and DBC groups, respectively, 0.0% and 1.6% of type II cases, and 0.0% and 3.2% of type III cases. The duodenal invasion was present in 12.5% and 17.7% of patients in the non&#x02010;DBC and DBC groups, respectively. Trainees were involved in 67.5% and 71.0% of cases in the non&#x02010;DBC and DBC groups, respectively. The absence of the ampullary bile duct was observed in 27.5% and 51.6% of patients in the non&#x02010;DBC and DBC groups, respectively.</p><table-wrap position="float" id="deo270092-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Univariate and multivariate analysis results of the predictive factors for difficult biliary cannulation.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr><th align="left" rowspan="2" colspan="1"/><th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">Difficult biliary cannulation</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">Univariate analysis</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">Multivariate analysis</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Yes (<italic toggle="yes">n</italic>&#x000a0;= 62)</th><th align="left" rowspan="1" colspan="1">No (<italic toggle="yes">n</italic>&#x000a0;= 40)</th><th align="left" rowspan="1" colspan="1">Unadjusted odds ratio (95% CI)</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th><th align="left" rowspan="1" colspan="1">Adjusted odds ratio (95% CI)</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" colspan="7" rowspan="1">Macroscopic appearance of the ampulla, <italic toggle="yes">n</italic> (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Type I</td><td align="left" rowspan="1" colspan="1">40 (64.5)</td><td align="left" rowspan="1" colspan="1">30 (75.0)</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Type II</td><td align="left" rowspan="1" colspan="1">3 (4.8)</td><td align="left" rowspan="1" colspan="1">4 (10.0)</td><td align="left" rowspan="1" colspan="1">0.461 (0.064&#x02013;2.897)</td><td align="left" rowspan="1" colspan="1">0.428</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Type III</td><td align="left" rowspan="1" colspan="1">19 (30.6)</td><td align="left" rowspan="1" colspan="1">5 (12.5)</td><td align="left" rowspan="1" colspan="1">3.061 (0.975&#x02013;11.57)</td><td align="left" rowspan="1" colspan="1">0.054</td><td align="left" rowspan="1" colspan="1">3.32 (1.07&#x02013;10.30)</td><td align="left" rowspan="1" colspan="1">0.04*</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Type IV</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td><td align="left" rowspan="1" colspan="1">1 (2.5)</td><td align="left" rowspan="1" colspan="1">0 (0.000&#x02013;25.16)</td><td align="left" rowspan="1" colspan="1">0.392</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="7" rowspan="1">Periampullary diverticulum, <italic toggle="yes">n</italic> (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No diverticulum</td><td align="left" rowspan="1" colspan="1">56 (90.3)</td><td align="left" rowspan="1" colspan="1">34 (85.0)</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Type I</td><td align="left" rowspan="1" colspan="1">3 (4.8)</td><td align="left" rowspan="1" colspan="1">6 (15.0)</td><td align="left" rowspan="1" colspan="1">0.292 (0.044&#x02013;1.471)</td><td align="left" rowspan="1" colspan="1">0.149</td><td align="left" rowspan="1" colspan="1">0.30 (0.07&#x02013;1.37)</td><td align="left" rowspan="1" colspan="1">0.12</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Type II</td><td align="left" rowspan="1" colspan="1">1 (1.6)</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td><td align="left" rowspan="1" colspan="1">Inf (0.016&#x02013;Inf)</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Type III</td><td align="left" rowspan="1" colspan="1">2 (3.2)</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td><td align="left" rowspan="1" colspan="1">Inf (0.121&#x02013;Inf)</td><td align="left" rowspan="1" colspan="1">0.519</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="7" rowspan="1">Duodenal invasion, <italic toggle="yes">n</italic> (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">51 (82.3)</td><td align="left" rowspan="1" colspan="1">35 (87.5)</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">11 (17.7)</td><td align="left" rowspan="1" colspan="1">5 (12.5)</td><td align="left" rowspan="1" colspan="1">1.503 (0.434&#x02013;6.022)</td><td align="left" rowspan="1" colspan="1">0.583</td><td align="left" rowspan="1" colspan="1">1.13 (0.32&#x02013;3.97)</td><td align="left" rowspan="1" colspan="1">0.85</td></tr><tr><td align="left" colspan="7" rowspan="1">Trainee involvement, <italic toggle="yes">n</italic> (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">18 (29.0)</td><td align="left" rowspan="1" colspan="1">13 (32.5)</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">44 (71.0)</td><td align="left" rowspan="1" colspan="1">27 (67.5)</td><td align="left" rowspan="1" colspan="1">1.175 (0.451&#x02013;3.012)</td><td align="left" rowspan="1" colspan="1">0.826</td><td align="left" rowspan="1" colspan="1">1.41 (0.55&#x02013;3.57)</td><td align="left" rowspan="1" colspan="1">0.47</td></tr><tr><td align="left" colspan="7" rowspan="1">The absence of the ampullary bile duct, <italic toggle="yes">n</italic> (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">30 (28.4)</td><td align="left" rowspan="1" colspan="1">29 (72.5)</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">32 (51.6)</td><td align="left" rowspan="1" colspan="1">11 (27.5)</td><td align="left" rowspan="1" colspan="1">2.783 (1.113&#x02013;7.334)</td><td align="left" rowspan="1" colspan="1">0.023*</td><td align="left" rowspan="1" colspan="1">2.58 (1.02&#x02013;6.51)</td><td align="left" rowspan="1" colspan="1">0.04*</td></tr></tbody></table><table-wrap-foot><fn id="deo270092-tbl2-note-0001"><p>95% CI, 95% Confidence Interval; Ref, reference.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>In the univariate analysis, the absence of the ampullary bile duct was significantly associated with DBC (odds ratio [OR]: 2.783; 95% confidence interval [95% CI]: 1.113&#x02013;7.334; <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.023).</p><p>In addition to all variables with <italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.2 in univariate analysis, trainee involvement and duodenal invasion were included in the multivariate analysis because they were considered significant variables clinically associated with DBC. In this analysis, type III (enlarged/protruding) papillary morphology, type I periampullary diverticulum, duodenal invasion, trainee involvement, and the absence of the ampullary bile duct were identified as factors related to DBC. Type III (enlarged/protruding) papillary morphology was significantly associated with DBC (OR: 3.32; 95% CI: 1.07&#x02013;10.30; <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.04). The absence of the ampullary bile duct was also significantly associated with DBC (OR: 2.58; (95% CI: 1.02&#x02013;6.51; <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.04).</p><p>The characteristics of patients without the ampullary bile duct are shown in Table&#x000a0;<xref rid="deo270092-tbl-0003" ref-type="table">3</xref>. Compared to those with the ampullary bile duct, patients without it had a significantly higher DBC rate (74.4%&#x000a0;vs. 50.8%) and longer cannulation times (19&#x000a0;min vs. 10&#x000a0;min). Additionally, alternative cannulation was more common in the group without the ampullary bile duct (61.3%&#x000a0;vs. 41.8%). No significant difference in the AE rates was observed between the two groups (9.4%&#x000a0;vs. 11.9%). The pancreatitis rate was lower in patients without the ampullary bile duct compared to those with it (4.7%&#x000a0;vs. 10.2%).</p><table-wrap position="float" id="deo270092-tbl-0003" content-type="TABLE"><label>TABLE 3</label><caption><p>Patient characteristics regarding the absence of the ampullary bile duct.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" colspan="3" style="border-bottom:solid 1px #000000" rowspan="1">Absence of the ampullary bile duct</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Yes (<italic toggle="yes">n</italic>&#x000a0;= 43)</th><th align="left" rowspan="1" colspan="1">No (<italic toggle="yes">n</italic>&#x000a0;= 59)</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Difficult biliary cannulation, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">32 (74.4)</td><td align="left" rowspan="1" colspan="1">30 (50.8)</td><td align="left" rowspan="1" colspan="1">0.023*</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">11 (25.6)</td><td align="left" rowspan="1" colspan="1">29 (49.2)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Cannulation time, median [IQR], (min)</td><td align="left" rowspan="1" colspan="1">19.00 (2&#x02013;54)</td><td align="left" rowspan="1" colspan="1">10.00 (2&#x02013;54)</td><td align="left" rowspan="1" colspan="1">0.01*</td></tr><tr><td align="left" rowspan="1" colspan="1">Bile duct stricture length on CT, median [IQR], (mm)</td><td align="left" rowspan="1" colspan="1">23.00 (1&#x02013;45)</td><td align="left" rowspan="1" colspan="1">25.00 (8&#x02013;42)</td><td align="left" rowspan="1" colspan="1">0.927</td></tr><tr><td align="left" rowspan="1" colspan="1">Cannulation method, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.021*</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Normal</td><td align="left" rowspan="1" colspan="1">16 (37.2)</td><td align="left" rowspan="1" colspan="1">33 (55.9)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Double&#x02010;guidewire</td><td align="left" rowspan="1" colspan="1">13 (30.2)</td><td align="left" rowspan="1" colspan="1">20 (33.9)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">TPBS</td><td align="left" rowspan="1" colspan="1">9 (20.9)</td><td align="left" rowspan="1" colspan="1">2 (3.4)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Direct precutting</td><td align="left" rowspan="1" colspan="1">5 (11.6)</td><td align="left" rowspan="1" colspan="1">4 (6.8)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Adverse event, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Pancreatitis</td><td align="left" rowspan="1" colspan="1">2 (4.7)</td><td align="left" rowspan="1" colspan="1">6 (10.2)</td><td align="left" rowspan="1" colspan="1">0.462</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Bleeding</td><td align="left" rowspan="1" colspan="1">2 (4.7)</td><td align="left" rowspan="1" colspan="1">1 (1.7)</td><td align="left" rowspan="1" colspan="1">0.572</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Perforation</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="deo270092-tbl3-note-0001"><p>Abbreviations: CT, computed tomography; IQR, interquartile range; TPBS, transpancreatic biliary sphincterotomy.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec></sec><sec id="deo270092-sec-0140"><title>DISCUSSION</title><p>This retrospective study was the first to investigate factors associated with DBC during ERCP for DMBO caused by pancreatic cancer. Successful bile duct cannulation is the most critical step in the ERCP procedure, and identifying predictive factors for DBC can benefit both patients with pancreatic cancer and endoscopists.</p><p>The incidence of DBC in DMBO caused by pancreatic cancer was 60.8%, which aligns with the 56.4% reported in the literature.<xref rid="deo270092-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> This high incidence highlights the significant risk that DMBO presents to successful biliary cannulation during ERCP, which is essential for guiding treatment decisions and discussing risks with patients. Multivariate analysis identified the absence of the ampullary bile duct and type III (enlarged/protruding) papillary morphology as primary factors influencing biliary cannulation. These findings highlight the important roles of papillary morphology and the status of the ampullary bile duct in successful bile duct cannulation.</p><p>ERCP has been extensively studied as a treatment for DMBO, with reported success and cannulation rates.<xref rid="deo270092-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="deo270092-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref>, <xref rid="deo270092-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="deo270092-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="deo270092-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="deo270092-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="deo270092-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> DMBO caused by pancreatic cancer often disrupts the anatomy of the duodenum and papilla, complicating endoscopic maneuvering.<xref rid="deo270092-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> In patients with pancreatic cancer, compromised biliary duct and changes in the duodenal mucosa can lead to AEs such as papillary edema and bleeding, further complicating the cannulation process.<xref rid="deo270092-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> Fugazza et&#x000a0;al. identified DMBO caused by pancreatic cancer as a risk factor for DBC, suggesting that tumor invasion into the ampulla is associated with DBC, while invasion into the duodenum is linked to ERCP failure.<xref rid="deo270092-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> In our study, cases of complete duodenal obstruction caused by tumor invasion were excluded, and duodenal invasion did not affect the predictive factors of DBC. While duodenal invasion, excluding papilla invasion, may impact endoscope mobility, it did not determine DBC. Future case accumulation may clarify the trends of DBC and ERCP failure by examining the degree and site of duodenal invasion. Even when tumor invasion is not visible during an endoscopy, the absence of the ampullary bile duct due to tumor involvement may prevent guide&#x02010;wire advancement along the correct route. In such cases, the guide wire may create a fistula or result in an intimal injection of contrast, leading to further swelling of the papilla and complicating bile duct intubation. Our study demonstrates that even in the absence of visible invasion, a tumor&#x02010;induced stricture that leads to the absence of the ampullary bile duct is a significant risk factor for DBC.</p><p>Herein, type III (enlarged/protruding) papillary morphology was considered a risk factor for DBC; however, a long, enlarged, or protruding papilla, such as type III, has been reported as a risk factor for DBC and is not limited to DMBO.<xref rid="deo270092-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>, <xref rid="deo270092-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> In such cases, correctly positioning the papilla in front of the bile duct axis is challenging. Moreover, switching from trainee to expert promptly or, if a wire can be inserted in the pancreatic duct, immediately consider alternative cannulation techniques.</p><p>Although previous studies have identified factors associated with DBC, such as trainee involvement<xref rid="deo270092-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="deo270092-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>, <xref rid="deo270092-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> and the presence of periampullary diverticula, <xref rid="deo270092-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="deo270092-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="deo270092-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> these were not significant risk factors in our analysis. While trainee involvement can extend procedural time and increase the likelihood of AEs after ERCP,<xref rid="deo270092-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref>, <xref rid="deo270092-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> evidence suggests it does not always increase AE rates.<xref rid="deo270092-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> In our study, trainee involvement was not a risk factor for DBC, possibly because trainees had prior ERCP experience and expert guidance was consistently available at our facility.</p><p>The overall AE rate in our cohort was 10.8% (11/102), comparable to incidence rates reported for all ERCP indications.<xref rid="deo270092-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> DBC increases the risk of AEs, as prolonged procedures increase the likelihood of PEP.<xref rid="deo270092-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="deo270092-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> Current literature supports TPBS and direct precutting as effective salvage techniques for DBC.<xref rid="deo270092-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref>, <xref rid="deo270092-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref>, <xref rid="deo270092-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref>, <xref rid="deo270092-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref>, <xref rid="deo270092-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref> Implementing an early alternative technique, rather than delaying after prolonged cannulation attempts, can improve safety and efficacy.<xref rid="deo270092-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> In our study, 85.4% (53/62) of patients in the DBC group underwent alternative cannulation methods, including TPBS or direct precutting. Prompt use of these techniques in patients with multiple DBC risk factors may improve procedural efficiency and reduce AEs. Additionally, DBC was significantly more common among patients without the ampullary bile duct, most of whom required alternative cannulation methods; however, these patients experienced fewer AEs (Table&#x000a0;<xref rid="deo270092-tbl-0003" ref-type="table">3</xref>). Patients without an ampullary bile duct had a lower rate of PEP compared to those with one. The reason for this remains unclear. One possible explanation is that when the ampullary bile duct is absent, the risk of PEP increases due to prolonged bile duct cannulation time and obstruction of the main pancreatic duct by a tumor near the papilla. However, the lower PEP rate may be attributed to the timing of the switch to an alternative cannulation method, which may explain why the incidence of PEP was lower in patients without an ampullary bile duct.</p><p>The effectiveness of EUS&#x02010;BD for DMBO has been documented, with studies comparing ERCP and EUS&#x02010;BD reporting fewer AEs with EUS&#x02010;BD.<xref rid="deo270092-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> Therefore, from a trainee education perspective, early transition to an alternative cannulation method is considered acceptable. However, when DBC is anticipated before ERCP, early conversion to EUS&#x02010;BD is preferable. as it may reduce the risk of AEs.</p><p>This study highlights the impact of anatomical factors on ERCP outcomes. Specifically, type III (enlarged/protruding) papillary morphology and the absence of the ampullary bile duct significantly influence DBC success. Therefore, these anatomical features should be carefully considered. While papillary morphology can only be assessed endoscopically, these findings underscore the importance of using computed tomography to evaluate the presence of the ampullary bile duct before ERCP in patients with DMBO caused by pancreatic cancer.</p><p>This study has some limitations. As a retrospective study, it may be subject to selection and data collection biases. While this study underscores the influence of the absence of the ampullary bile duct on ERCP success, the specific anatomical factors influencing DBC remain unclear. Future research is needed to clarify how specific aspects of the papillary morphology and anatomical structure contribute to DBC.</p><p>In summary, this study identifies type III (enlarged/protruding) papillary morphology and the absence of the ampullary bile duct as key factors contributing to DBC during ERCP in patients with DMBO caused by pancreatic cancer. Recognizing the absence of the ampullary bile duct before ERCP and promptly employing alternative cannulation techniques or converting to EUS&#x02010;BD could improve patient safety.</p></sec><sec sec-type="COI-statement" id="deo270092-sec-0150"><title>CONFLICT OF INTEREST STATEMENT</title><p>None.</p></sec><sec id="deo270092-sec-0160"><title>ETHICS STATEMENT</title><p>Approval of the research protocol by an Institutional Reviewer Board: This study was approved by the Institutional Review Board of the hospital on April 21, 2024.</p></sec><sec id="deo270092-sec-0170"><title>PATIENT CONSENT STATEMENT</title><p>The requirement for written informed consent from the patients was waived due to the retrospective nature of the study.</p></sec><sec id="deo270092-sec-0180"><title>CLINICAL TRIAL REGISTRATION</title><p>N/A.</p></sec></body><back><ref-list id="deo270092-bibl-0001"><title>REFERENCES</title><ref id="deo270092-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="deo270092-cite-0001">
<string-name>
<surname>Bourke</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Costamagna</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Freeman</surname>
<given-names>ML</given-names>
</string-name>. <article-title>Biliary cannulation during endoscopic retrograde cholangiopancreatography: Core technique and recent innovations</article-title>. <source>Endoscopy</source>
<year>2009</year>; <volume>41</volume>: <fpage>612</fpage>&#x02013;<lpage>617</lpage>.<pub-id pub-id-type="pmid">19588290</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="deo270092-cite-0002">
<string-name>
<surname>Dumonceau</surname>
<given-names>J&#x02010;M</given-names>
</string-name>, <string-name>
<surname>Tringali</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Papanikolaou</surname>
<given-names>IS</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Endoscopic biliary stenting: Indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline &#x02013; Updated October 2017</article-title>. <source>Endoscopy</source>
<year>2018</year>; <volume>50</volume>: <fpage>910</fpage>&#x02013;<lpage>930</lpage>.<pub-id pub-id-type="pmid">30086596</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="deo270092-cite-0003">
<string-name>
<surname>Yoo</surname>
<given-names>YW</given-names>
</string-name>, <string-name>
<surname>Cha</surname>
<given-names>S&#x02010;W</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>WC</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Cho</surname>
<given-names>YD</given-names>
</string-name>. <article-title>Double guide&#x02010;wire technique vs transpancreatic precut sphincterotomy in difficult biliary cannulation</article-title>. <source>World J Gastroenterol</source>
<year>2013</year>; <volume>19</volume>: <fpage>108</fpage>&#x02013;<lpage>114</lpage>.<pub-id pub-id-type="pmid">23326171</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="deo270092-cite-0004">
<string-name>
<surname>Maeda</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hayashi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hosokawa</surname>
<given-names>O</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Prospective randomized pilot trial of selective biliary cannulation using pancreatic guide&#x02010;wire placement</article-title>. <source>Endoscopy</source>
<year>2003</year>; <volume>35</volume>: <fpage>721</fpage>&#x02013;<lpage>724</lpage>.<pub-id pub-id-type="pmid">12929017</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="deo270092-cite-0005">
<string-name>
<surname>Williams</surname>
<given-names>EJ</given-names>
</string-name>, <string-name>
<surname>Ogollah</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Thomas</surname>
<given-names>P</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>What predicts failed cannulation and therapy at ERCP? Results of a large&#x02010;scale multicenter analysis</article-title>. <source>Endoscopy</source>
<year>2012</year>; <volume>44</volume>: <fpage>674</fpage>&#x02013;<lpage>683</lpage>.<pub-id pub-id-type="pmid">22696192</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="deo270092-cite-0006">
<string-name>
<surname>Ismail</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Udd</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lindstr&#x000f6;m</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Rainio</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Halttunen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kyl&#x000e4;np&#x000e4;&#x000e4;</surname>
<given-names>L</given-names>
</string-name>. <article-title>Criteria for difficult biliary cannulation: Start to count</article-title>. <source>Eur J Gastroenterol Hepatol</source>
<year>2019</year>; <volume>31</volume>: <fpage>1200</fpage>&#x02013;<lpage>1205</lpage>.<pub-id pub-id-type="pmid">31464778</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="deo270092-cite-0007">
<string-name>
<surname>Sabbah</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nakhli</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bellil</surname>
<given-names>N</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Predictors of failure of endoscopic retrograde pancreatocholangiography during common bile duct stones</article-title>. <source>Heliyon</source>
<year>2020</year>; <volume>6</volume>: <elocation-id>e05515</elocation-id>.<pub-id pub-id-type="pmid">33294669</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="deo270092-cite-0008">
<string-name>
<surname>Tabak</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>H&#x02010;S</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Q&#x02010;P</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Endoscopic retrograde cholangiopancreatography in elderly patients: Difficult cannulation and adverse events</article-title>. <source>World J Clin Cases</source>
<year>2020</year>; <volume>8</volume>: <fpage>2988</fpage>&#x02013;<lpage>2999</lpage>.<pub-id pub-id-type="pmid">32775380</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="deo270092-cite-0009">
<string-name>
<surname>Chen</surname>
<given-names>P&#x02010;H</given-names>
</string-name>, <string-name>
<surname>Tung</surname>
<given-names>C&#x02010;F</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>Y&#x02010;C</given-names>
</string-name>, <string-name>
<surname>Yeh</surname>
<given-names>H&#x02010;Z</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>C&#x02010;S</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>C&#x02010;C</given-names>
</string-name>. <article-title>Duodenal major papilla morphology can affect biliary cannulation and complications during ERCP, an observational study</article-title>. <source>BMC Gastroenterol</source>
<year>2020</year>; <volume>20</volume>: <fpage>310</fpage>.<pub-id pub-id-type="pmid">32988368</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="deo270092-cite-0010">
<string-name>
<surname>C&#x000e1;ceres&#x02010;Escobar</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Mu&#x000f1;oz&#x02010;Velandia</surname>
<given-names>OM</given-names>
</string-name>, <string-name>
<surname>Vargas&#x02010;Rubio</surname>
<given-names>R</given-names>
</string-name>. <article-title>Factors associated with difficult biliary cannulation in a training center for endoscopic intervention of the biliary tract</article-title>. <source>Arq Gastroenterol</source>
<year>2022</year>; <volume>59</volume>: <fpage>29</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">35442332</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="deo270092-cite-0011">
<string-name>
<surname>Fugazza</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Troncone</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Amato</surname>
<given-names>A</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Difficult biliary cannulation in patients with distal malignant biliary obstruction: An underestimated problem?</article-title>
<source>Dig Liver Dis</source>
<year>2022</year>; <volume>54</volume>: <fpage>529</fpage>&#x02013;<lpage>536</lpage>.<pub-id pub-id-type="pmid">34362708</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="deo270092-cite-0012">
<string-name>
<surname>Saito</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kadono</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Shono</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Factors predicting difficult biliary cannulation during endoscopic retrograde cholangiopancreatography for common bile duct stones</article-title>. <source>Clin Endosc</source>
<year>2022</year>; <volume>55</volume>: <fpage>263</fpage>&#x02013;<lpage>269</lpage>.<pub-id pub-id-type="pmid">34763384</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="deo270092-cite-0013">
<string-name>
<surname>Ben Abdallah</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hamzaoui</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Mahmoudi</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Predictive factors of difficult biliary cannulation: An experience of a Tunisian tertiary center</article-title>. <source>Heliyon</source>
<year>2022</year>; <volume>8</volume>: <elocation-id>e12526</elocation-id>.<pub-id pub-id-type="pmid">36619425</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="deo270092-cite-0014">
<string-name>
<surname>Stark</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hines</surname>
<given-names>OJ</given-names>
</string-name>. <article-title>Endoscopic and operative palliation strategies for pancreatic ductal adenocarcinoma</article-title>. <source>Semin Oncol</source>
<year>2015</year>; <volume>42</volume>: <fpage>163</fpage>&#x02013;<lpage>176</lpage>.<pub-id pub-id-type="pmid">25726060</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="deo270092-cite-0015">
<string-name>
<surname>Mandai</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Uno</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Fujii</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kawamura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yasuda</surname>
<given-names>K</given-names>
</string-name>. <article-title>Number of endoscopic retrograde cholangiopancreatography procedures required for short biliary cannulation time</article-title>. <source>Gastroenterol Res Pract</source>
<volume>2017</volume>; <year>2017</year>: <elocation-id>1515260</elocation-id>.<pub-id pub-id-type="pmid">28487727</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="deo270092-cite-0016">
<string-name>
<surname>Freeman</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Guda</surname>
<given-names>NM</given-names>
</string-name>. <article-title>ERCP cannulation: A review of reported techniques</article-title>. <source>Gastrointest Endosc</source>
<year>2005</year>; <volume>61</volume>: <fpage>112</fpage>&#x02013;<lpage>125</lpage>.<pub-id pub-id-type="pmid">15672074</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="deo270092-cite-0017">
<string-name>
<surname>Yokoe</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hata</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Tokyo Guidelines 2018: Diagnostic criteria and severity grading of acute cholecystitis (with videos)</article-title>. <source>J Hepatobiliary Pancreat Sci</source>
<year>2018</year>; <volume>25</volume>: <fpage>41</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">29032636</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="deo270092-cite-0018">
<string-name>
<surname>Ishida</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Fujii</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kishiwada</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Japanese classification of pancreatic carcinoma by the Japan Pancreas Society: Eighth edition</article-title>. <source>J Hepatobiliary Pancreat Sci</source>
<year>2024</year>; <volume>31</volume>: <fpage>755</fpage>&#x02013;<lpage>768</lpage>.<pub-id pub-id-type="pmid">39074998</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="deo270092-cite-0019">
<string-name>
<surname>Haraldsson</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kyl&#x000e4;np&#x000e4;&#x000e4;</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Gr&#x000f6;nroos</surname>
<given-names>J</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Macroscopic appearance of the major duodenal papilla influences bile duct cannulation: A prospective multicenter study by the Scandinavian Association for Digestive Endoscopy Study Group for ERCP</article-title>. <source>Gastrointest Endosc</source>
<year>2019</year>; <volume>90</volume>: <fpage>957</fpage>&#x02013;<lpage>963</lpage>.<pub-id pub-id-type="pmid">31326385</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="deo270092-cite-0020">
<string-name>
<surname>Boix</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lorenzo&#x02010;Z&#x000fa;&#x000f1;iga</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>A&#x000f1;a&#x000f1;os</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Dom&#x000e8;nech</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Morillas</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Gassull</surname>
<given-names>MA</given-names>
</string-name>. <article-title>Impact of periampullary duodenal diverticula at endoscopic retrograde cholangiopancreatography: A proposed classification of periampullary duodenal diverticula</article-title>. <source>Surg Laparosc Endosc Percutan Tech</source>
<year>2006</year>; <volume>16</volume>: <fpage>208</fpage>&#x02013;<lpage>211</lpage>.<pub-id pub-id-type="pmid">16921297</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="deo270092-cite-0021">
<string-name>
<surname>Verma</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Gostout</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Petersen</surname>
<given-names>BT</given-names>
</string-name>, <string-name>
<surname>Levy</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Baron</surname>
<given-names>TH</given-names>
</string-name>, <string-name>
<surname>Adler</surname>
<given-names>DG</given-names>
</string-name>. <article-title>Establishing a true assessment of endoscopic competence in ERCP during training and beyond: A single&#x02010;operator learning curve for deep biliary cannulation in patients with native papillary anatomy</article-title>. <source>Gastrointest Endosc</source>
<year>2007</year>; <volume>65</volume>: <fpage>394</fpage>&#x02013;<lpage>400</lpage>.<pub-id pub-id-type="pmid">17321237</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="deo270092-cite-0022">
<string-name>
<surname>Cotton</surname>
<given-names>PB</given-names>
</string-name>, <string-name>
<surname>Eisen</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Aabakken</surname>
<given-names>L</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>A lexicon for endoscopic adverse events: Report of an ASGE workshop</article-title>. <source>Gastrointest Endosc</source>
<year>2010</year>; <volume>71</volume>: <fpage>446</fpage>&#x02013;<lpage>454</lpage>.<pub-id pub-id-type="pmid">20189503</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="deo270092-cite-0023">
<string-name>
<surname>Berry</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>JY</given-names>
</string-name>, <string-name>
<surname>Tabibian</surname>
<given-names>JH</given-names>
</string-name>. <article-title>Difficult biliary cannulation: Historical perspective, practical updates, and guide for the endoscopist</article-title>. <source>World J Gastrointest Endosc</source>
<year>2019</year>; <volume>11</volume>: <fpage>5</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">30705728</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="deo270092-cite-0024">
<string-name>
<surname>Watanabe</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Okuwaki</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kida</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Transpapillary biliary cannulation is difficult in cases with large oral protrusion of the duodenal papilla</article-title>. <source>Dig Dis Sci</source>
<year>2019</year>; <volume>64</volume>: <fpage>2291</fpage>&#x02013;<lpage>2299</lpage>.<pub-id pub-id-type="pmid">30746630</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="deo270092-cite-0025">
<string-name>
<surname>Cheng</surname>
<given-names>C&#x02010;L</given-names>
</string-name>, <string-name>
<surname>Sherman</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Watkins</surname>
<given-names>JL</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Risk factors for post&#x02010;ERCP pancreatitis: A prospective multicenter study</article-title>. <source>Am J Gastroenterol</source>
<year>2006</year>; <volume>101</volume>: <fpage>139</fpage>&#x02013;<lpage>147</lpage>.<pub-id pub-id-type="pmid">16405547</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="deo270092-cite-0026">
<string-name>
<surname>Lee</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Cho</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Heo</surname>
<given-names>J</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Impact of hospital volume and the experience of endoscopist on adverse events related to endoscopic retrograde cholangiopancreatography: A prospective observational study</article-title>. <source>Gut Liver</source>
<year>2020</year>; <volume>14</volume>: <fpage>257</fpage>&#x02013;<lpage>264</lpage>.<pub-id pub-id-type="pmid">31060119</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="deo270092-cite-0027">
<string-name>
<surname>Rabenstein</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Schneider</surname>
<given-names>HT</given-names>
</string-name>, <string-name>
<surname>Bulling</surname>
<given-names>D</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Analysis of the risk factors associated with endoscopic sphincterotomy techniques: Preliminary results of a prospective study, with emphasis on the reduced risk of acute pancreatitis with low&#x02010;dose anticoagulation treatment</article-title>. <source>Endoscopy</source>
<year>2000</year>; <volume>32</volume>: <fpage>10</fpage>&#x02013;<lpage>19</lpage>.<pub-id pub-id-type="pmid">10691266</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="deo270092-cite-0028">
<string-name>
<surname>Andriulli</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Loperfido</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Napolitano</surname>
<given-names>G</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Incidence rates of post&#x02010;ERCP complications: A systematic survey of prospective studies</article-title>. <source>Am J Gastroenterol</source>
<year>2007</year>; <volume>102</volume>: <fpage>1781</fpage>&#x02013;<lpage>1788</lpage>.<pub-id pub-id-type="pmid">17509029</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="deo270092-cite-0029">
<string-name>
<surname>Halttunen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Meisner</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Aabakken</surname>
<given-names>L</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Difficult cannulation as defined by a prospective study of the Scandinavian Association for Digestive Endoscopy (SADE) in 907 ERCPs</article-title>. <source>Scand J Gastroenterol</source>
<year>2014</year>; <volume>49</volume>: <fpage>752</fpage>&#x02013;<lpage>758</lpage>.<pub-id pub-id-type="pmid">24628493</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="deo270092-cite-0030">
<string-name>
<surname>Cennamo</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Fuccio</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zagari</surname>
<given-names>RM</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Can early precut implementation reduce endoscopic retrograde cholangiopancreatography&#x02010;related complication risk? Meta&#x02010;analysis of randomized controlled trials</article-title>. <source>Endoscopy</source>
<year>2010</year>; <volume>42</volume>: <fpage>381</fpage>&#x02013;<lpage>388</lpage>.<pub-id pub-id-type="pmid">20306386</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="deo270092-cite-0031">
<string-name>
<surname>Takano</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Nagahama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Niiya</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Kobayashi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yamamura</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Maruoka</surname>
<given-names>N</given-names>
</string-name>. <article-title>Optimal timing for precutting in cases with difficult biliary cannulation</article-title>. <source>Endosc Int Open</source>
<year>2018</year>; <volume>6</volume>: <fpage>E1015</fpage>&#x02013;<lpage>E1019</lpage>.<pub-id pub-id-type="pmid">30105288</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="deo270092-cite-0032">
<string-name>
<surname>Ikeda</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ono</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ohmori</surname>
<given-names>G</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Clinical benefit of early precut sphincintroterotomy for difficult biliary cannulation during endoscopic retrograde cholangiopancreatography</article-title>. <source>Surg Endosc</source>
<year>2023</year>; <volume>37</volume>: <fpage>120</fpage>&#x02013;<lpage>126</lpage>.<pub-id pub-id-type="pmid">35851815</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="deo270092-cite-0033">
<string-name>
<surname>Kyl&#x000e4;np&#x000e4;&#x000e4;</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Koskensalo</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Saarela</surname>
<given-names>A</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Transpancreatic biliary sphincterotomy versus double guide&#x02010;wire in difficult biliary cannulation: A randomized controlled trial</article-title>. <source>Endoscopy</source>
<year>2021</year>; <volume>53</volume>: <fpage>1011</fpage>&#x02013;<lpage>1019</lpage>.<pub-id pub-id-type="pmid">33440441</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="deo270092-cite-0034">
<string-name>
<surname>Sugiyama</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tsuyuguchi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sakai</surname>
<given-names>Y</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Transpancreatic precut papillotomy versus double&#x02010;guidewire technique in difficult biliary cannulation: Prospective randomized study</article-title>. <source>Endoscopy</source>
<year>2018</year>; <volume>50</volume>: <fpage>33</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="pmid">29020689</pub-id>
</mixed-citation></ref><ref id="deo270092-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="deo270092-cite-0035">
<string-name>
<surname>Ogura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ishiwatari</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hijioka</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Multicenter study comparing EUS&#x02010;guided hepaticogastrostomy and ERCP for malignant biliary obstruction in patients with accessible papillae</article-title>. <source>J Hepatobiliary Pancreat Sci</source>
<year>2024</year>; <volume>31</volume>: <fpage>680</fpage>&#x02013;<lpage>687</lpage>.<pub-id pub-id-type="pmid">39022838</pub-id>
</mixed-citation></ref></ref-list></back></article>